Sector ratings Boston Scientific Corporation
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.64 USD | -1.54% |
|
-9.04% | -6.85% |
| 01:17pm | Oppenheimer Adjusts Price Target on Boston Scientific to $100 From $125, Maintains Outperform Rating | MT |
| 09:03am | RTW Biotech's portfolio firm Penumbra acquired by Boston Scientific | AN |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 133B | BBB | ||||||||
| 235B | BB | ||||||||
| 192B | BBB | ||||||||
| 169B | AA | ||||||||
| 60.62B | BBB | ||||||||
| 49.03B | AAA | ||||||||
| 41.06B | AA | ||||||||
| 37.59B | A | ||||||||
| 37.97B | A | ||||||||
| 35.43B | AA | ||||||||
| 28.79B | B | ||||||||
| 27.92B | - | - | - | - | - | - | - | ||
| 23.49B | AAA | ||||||||
| 22.2B | BBB | ||||||||
| 17.19B | - | - | - | - | - | - | - | ||
| 16.72B | AA | ||||||||
| 14.4B | BB | ||||||||
| 13.08B | AAA | ||||||||
| 6.88B | - | - | - | - | |||||
| 7.52B | A | ||||||||
| Average | 58.47B | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















